Brian Bassiri-Tehrani

Brian Bassiri-Tehrani

Auto-generated profile, based on publicly available information

Brian Bassiri-Tehrani

Plastic surgeon in private practice in New York, New York, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
JAJad Abi-Rafeh
Jad Abi-Rafeh
NHNader Henry
Nader Henry
HXHong Hao Xu
Hong Hao Xu
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
AAAdel Arezki
Adel Arezki
FNFoad Nahai
Foad Nahai
Background: Large language models (LLMs) have revolutionized the way plastic surgeons and their patients can access and leverage artificial intelligence (AI). Objectives: The present study aims to compare the performance of 2 current publicly available and patient-accessible LLMs in the potential application of AI as postoperative medical support chatbots in an aesthetic surgeon's practice. Methods: Twenty-two simulated postoperative patient presentations following aesthetic breast plastic surgery were devised and expert-validated. Complications varied in their latency within the postoperative period, as well as urgency of required medical attention. In response to each patient-reported presentation, Open AI's ChatGPT and Google's Bard, in their unmodified and freely available versions, were objectively assessed for their comparative accuracy in generating an appropriate differential diagnosis, most-likely diagnosis, suggested medical disposition, treatments or interventions to begin from home, and/or red flag signs/symptoms indicating deterioration. Results: ChatGPT cumulatively and significantly outperformed Bard across all objective assessment metrics examined (66% vs 55%, respectively; P < .05). Accuracy in generating an appropriate differential diagnosis was 61% for ChatGPT vs 57% for Bard (P = .45). ChatGPT asked an average of 9.2 questions on history vs Bard’s 6.8 questions (P < .001), with accuracies of 91% vs 68% reporting the most-likely diagnosis, respectively (P < .01). Appropriate medical dispositions were suggested with accuracies of 50% by ChatGPT vs 41% by Bard (P = .40); appropriate home interventions/treatments with accuracies of 59% vs 55% (P = .94), and red flag signs/symptoms with accuracies of 79% vs 54% (P < .01), respectively. Detailed and comparative performance breakdowns according to complication latency and urgency are presented. Conclusions: ChatGPT represents the superior LLM for the potential application of AI technology in postoperative medical support chatbots. Imperfect performance and limitations discussed may guide the necessary refinement to facilitate adoption.

8 May 2023 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
PCPhaedra E Cress
Phaedra E Cress
Artificial Intelligence (AI) technology has become increasingly popular in the last few months. AI software has limitless applications in various industries, including plastic surgery. While AI technology is promising, there are some drawbacks. In the field of plastic surgery, AI tools can be used to streamline research projects, patient education materials and instructions, social media and marketing and more. Conversely, AI tools can also be abused, and can infringe on copyrights, lead to plagiarism, disseminate misinformation, threaten job security in various fields and limit original creativity. In conclusion, ChatGPT (OpenAI, San Francisco, CA) can be used responsibly to rapidly disseminate information and communications while improving overall efficiency in practice; however, if misused or abused, ChatGPT can lead to ethical issues, unknown and unintended consequences.

5 August 2023 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
CSChristopher M Stewart
Christopher M Stewart
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
HJHannah Elizabeth Jones
Hannah Elizabeth Jones
FNFoad Nahai
Foad Nahai
: Hematoma is a common complication after facelift procedures. Multiple factors have been shown to increase the risk of hematoma formation, such as male gender, anticoagulant medication use, perioperative hypertension, increased intrathoracic pressure, and operative technique. The purpose of this manuscript is to provide an overview of existing literature to provide surgeons with evidence-based recommendations on how to minimize hematoma risk during facelift surgery. A literature search for hematoma and facelift surgery was performed that identified 478 unique manuscripts. Abstracts were reviewed, excluding articles not describing facelift surgery, those written before 1970, studies with a sample size of fewer than 5 patients, non-English studies, and those that did not provide postoperative hematoma rates. Forty-five articles were included in this text, with their recommendations. Measures such as the prophylactic management of pain, nausea, and hypertension, the use of fibrin glue tissue sealants, the use of local anesthesia rather than general anesthesia, and strict blood pressure control of at least <140 mmHg were found to significantly reduce hematoma formation. Quilting sutures has shown benefit in some high-risk patients. Measures such as drains, compression dressings, perioperative use of selective serotonin reuptake inhibitors, and perioperative steroids had no significant effect on hematoma formation. In addition to appropriate patient selection and careful intraoperative hemostasis, many adjunct measures have been shown to reduce postoperative hematoma formation in facelift procedures. Level of Evidence: 3:

4 January 2024 in Aesthetic Surgery Journal Open Forum
Verified
Journal Article
Open access
PDF file
JAJad Abi-Rafeh
Jad Abi-Rafeh
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
RKRoy Kazan
Roy Kazan
HFHeather Furnas
Heather Furnas
DHDennis Hammond
Dennis Hammond
FNFoad Nahai
Foad Nahai
Background: At a time when Internet and social media use is omnipresent among patients in their self-directed research about their medical or surgical needs, artificial intelligence (AI) large language models (LLMs) are on track to represent hallmark resources in this context. Objectives: The authors aim to explore and assess the performance of a novel AI LLM in answering questions posed by simulated patients interested in aesthetic breast plastic surgery procedures. Methods: A publicly available AI LLM was queried using simulated interactions from the perspective of patients interested in breast augmentation, mastopexy, and breast reduction. Questions posed were standardized and categorized under aesthetic needs inquiries and awareness of appropriate procedures; patient candidacy and indications; procedure safety and risks; procedure information, steps, and techniques; patient assessment; preparation for surgery; postprocedure instructions and recovery; and procedure cost and surgeon recommendations. Using standardized Likert scales ranging from 1 to 10, 4 expert breast plastic surgeons evaluated responses provided by AI. A postparticipation survey assessed expert evaluators' experience with LLM technology, perceived utility, and limitations. Results: The overall performance across all question categories, assessment criteria, and procedures examined was 7.3/10 ± 0.5. Overall accuracy of information shared was scored at 7.1/10 ± 0.5; comprehensiveness at 7.0/10 ± 0.6; objectivity at 7.5/10 ± 0.4; safety at 7.5/10 ± 0.4; communication clarity at 7.3/10 ± 0.2; and acknowledgment of limitations at 7.7/10 ± 0.2. With regards to performance on procedures examined, the model's overall score was 7.0/10 ± 0.8 for breast augmentation; 7.6/10 ± 0.5 for mastopexy; and 7.4/10 ± 0.5 for breast reduction. The score on breast implant–specific knowledge was 6.7/10 ± 0.6. Conclusions: Albeit not without limitations, AI LLMs represent promising resources for patient guidance and patient education. The technology's machine learning capabilities may explain its improved performance efficiency. Level of Evidence: 4:

12 July 2023 in Aesthetic Surgery Journal
Verified
Journal Article
Open access
PDF file
FNFoad Nahai
Foad Nahai
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
KSKatherine B Santosa
Katherine B Santosa
Hematoma after face- or necklift is a significant complication with the potential for devastating consequences such as airway obstruction and skin necrosis. Reported incidence rates range from 0.6% to 14.2%.1-6 Previous studies have identified a number of predisposing patient-level factors as contributors to hematoma formation, including male sex and pre-existing hypertension;1-3 procedure-specific factors such as intraoperative blood loss; postoperative blood pressure;4,5 and ingestion of medications that affect coagulation and platelet function. We firmly believe that postoperative blood pressure elevation is the most common and prime etiological factor. In 1976, Berner et al first recognized the link between hypertension and hematoma following facelifts.6 That landmark study connected blood pressure elevation with postoperative bleeding and suggested controlling blood pressure with chlorpromazine.6 Since then, multiple studies have reported on the relationship between elevated systolic pressure and hematoma.1,2,7,8 Controlling postoperative blood pressure with antihypertensive agents such as clonidine, beta-blockers, and calcium-channel blockers has been shown to effectively reduce hematoma rates.9-12 Additionally, postoperative anxiety, a full bladder, and nausea/vomiting also contribute to blood pressure elevation.13 Beyond blood pressure control, tissue glues, compression dressings, and cooling devices have been advocated for hematoma reduction.14-19

1 May 2015 in Clinical Imaging
Verified
Journal Article
Closed access
NMNathaniel E. Margolis
Nathaniel E. Margolis
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
CCChloe Chhor
Chloe Chhor
CSCory Singer
Cory Singer
OHOsvaldo Hernandez
Osvaldo Hernandez
LMLinda Moy
Linda Moy